Effects of 7 years of growth hormone replacement therapy in hypopituitary adults

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3762-3769

  Chrisoulidou, A ^a   Beshyah, S A ^a   Rutherford, O ^a   Spinks, T J ^a   Mayet, J ^a   Kyd, P ^a   Anyaoku, V ^a   Haida, A ^a   Ariff, B ^a   Murphy, M ^a   Thomas, E ^a   Robinson, S ^a   Foale, R ^a   Johnston, D G ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; LIPID;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; DOPPLER ECHOCARDIOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE TOLERANCE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; HYPOPITUITARISM; IMPEDANCE; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0033756446     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.10.3762     Document Type: Article

References (48)

1. The growth hormone deficiency syndrome in adults
2. The use of growth hormone in adults: A changing scene
3. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency
4. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
5. Myocardial dysfunction in treated adult hypopituitarism: A possible explanation for increased cardiovascular mortality
6. Cardiovascular effects of prolonged growth hormone replacement in adults
7. Body composition in growth hormone deficient adults over the age of 60 years
8. Metabolic abnormalities in growth hormone-deficient adults II. Carbohydrate tolerance and lipid metabolism
9. Comparison of measurements of body composition by total body potassium, bioimpedance analysis, and dual-energy x-ray absorptiometry in hypopituitary adults before and during growth hormone treatment
10. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults
11. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults
12. Measurement of total body calcium in bone disease
13. The relationship of total body potassium to height, weight and age in normal adults
14. Estimation of total body water by bioelectrical-impedance analysis
15. Studies on body composition, body water and chemically combined nitrogen content in relation to fat content
16. Dual-energy x-ray absorptiometry for total and regional bone-mineral and soft-tissue composition
17. Insulin and C-peptide levels after oral and intravenous glucose
18. The measurement of insulin like growth factor 1: Clinical applications and significance
19. Enzymatic determination of total serum cholesterol
20. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol
21. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
22. Modified colirimetric ultramicro method for estimating NEFA in serum
23. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: Initial results
24. Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. II. Clinical studies
25. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults
26. Effects of four years' treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults
27. Effects of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency
28. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients
29. Serum lipids in growth hormone deficient men
30. Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: An interim report
31. Clinical aspects of growth hormone deficiency in adults
32. Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: The effect of growth hormone replacement and a comparison with control subjects
33. The effects of 3 months of recombinant growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: A minimal model analysis
34. Growth hormone treatment of growth hormone deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations
35. Human growth hormone and human aging
36. Ageing and growth hormone status
37. Predictive value of waist-to-hip ratio on cardiovascular risk events
38. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12-month placebo-controlled study
39. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
40. Premature mortality due to cardiovascular disease in hypopituitarism
41. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults
42. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults
43. Cardiovascular and renal effects of growth hormone
44. Cardiovascular aspects of growth hormone replacement therapy in adults
45. Left ventricular hypertrophy as a risk factor in arterial hypertension
46. Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function
47. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise
48. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults